Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study

BACKGROUND: Atherogenic dyslipidemia is associated with poor cardiovascular outcomes, yet markers of this condition are often ignored in clinical practice. Here, we address a clear evidence gap by assessing the prevalence and treatment of two markers of atherogenic dyslipidemia: elevated triglycerid...

Descripción completa

Detalles Bibliográficos
Autores principales: Halcox, Julian P., Banegas, José R., Roy, Carine, Dallongeville, Jean, De Backer, Guy, Guallar, Eliseo, Perk, Joep, Hajage, David, Henriksson, Karin M., Borghi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473961/
https://www.ncbi.nlm.nih.gov/pubmed/28623902
http://dx.doi.org/10.1186/s12872-017-0591-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473961/
https://www.ncbi.nlm.nih.gov/pubmed/28623902
http://dx.doi.org/10.1186/s12872-017-0591-5

Ejemplares similares